This supports our hypothesis that in high-MUC1 PDA cells, STAT3-MUC1 interaction and signaling is constitutively activated as a survival pathway and Napabucasin inhibits this pathway. The gene discussed is STAT3; the disease is Patent ductus arteriosus.